Drug Profile
FROST 900
Alternative Names: FROST-900Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Frost Biologic
- Class Antibacterials; Small molecules
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Helicobacter infections
Highest Development Phases
- No development reported Helicobacter infections
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Helicobacter-infections in USA (PO)
- 28 Jul 2016 FROST 900 is available for licensing as of 28 Jul 2016. http://www.frostbiologic.com/
- 28 Jul 2016 Early research in Helicobacter infections in USA (PO)